Evaxion Biotech A/S (EVAX) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free EVAX Stock Alerts $4.24 +0.02 (+0.47%) (As of 10:00 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Evaxion Biotech A/S Short Interest DataCurrent Short Volume42,600 sharesPrevious Short Volume43,000 sharesChange Vs. Previous Month-0.93%Dollar Volume Sold Short$136,320.00Short Interest Ratio / Days to Cover0.1Last Record DateMarch 31, 2024Outstanding Shares5,220,000 sharesPercentage of Shares Shorted0.82%Today's Trading Volume2,994 sharesAverage Trading Volume565,420 sharesToday's Volume Vs. Average1% Short Selling Evaxion Biotech A/S ? Sign up to receive the latest short interest report for Evaxion Biotech A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEVAX Short Interest Over TimeEVAX Days to Cover Over TimeEVAX Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Evaxion Biotech A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202442,600 shares $136,320.00 -0.9%N/A0.1 $3.20 3/15/202443,000 shares $128,570.00 +56.4%N/A0.1 $2.99 2/29/202427,500 shares $99,000.00 +41.8%N/A0 $3.60 2/15/202419,400 shares $80,510.00 -61.0%N/A0 $4.15 1/31/202449,800 shares $195,714.00 +325.6%N/A0.1 $3.93 1/15/202411,700 shares $93,483.00 -92.5%N/A0.4 $7.99 Get the Latest News and Ratings for EVAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evaxion Biotech A/S and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023155,800 shares $106,832.06 -9.1%N/A1.7 $0.69 12/15/2023171,400 shares $113,124.00 -26.9%N/A1.8 $0.66 11/30/2023234,300 shares $187,205.70 +7.8%N/A1.5 $0.80 11/15/2023217,400 shares $161,963.00 -22.8%N/A1.5 $0.75 10/31/2023281,600 shares $315,392.00 -22.5%N/A2.1 $1.12 10/15/2023363,400 shares $308,526.60 -31.6%N/A3.1 $0.85 9/30/2023531,500 shares $442,739.50 +118.9%N/A4.6 $0.83 9/15/2023242,800 shares $182,609.88 +38.5%N/A2.2 $0.75 8/31/2023175,300 shares $145,516.53 -23.8%N/A2.8 $0.83 8/15/2023230,000 shares $233,059.00 -30.7%N/A1.1 $1.01 7/31/2023331,700 shares $411,308.00 -9.9%N/A1.5 $1.24 7/15/2023368,000 shares $463,680.00 -15.6%N/A1.8 $1.26 6/30/2023436,200 shares $567,060.00 -18.4%N/A1.9 $1.30 6/15/2023534,300 shares $694,590.00 +110.1%N/A2.2 $1.30 5/31/2023254,300 shares $386,536.00 -4.0%N/A1.1 $1.52 5/15/2023264,800 shares $415,736.00 +5.5%N/A2.8 $1.57 4/30/2023251,100 shares $316,386.00 -34.3%N/A0.7 $1.26 4/15/2023382,100 shares $596,076.00 -12.1%N/A1 $1.56 3/31/2023434,700 shares $491,211.00 +24.2%N/A1 $1.13 3/15/2023350,100 shares $378,108.00 +31.6%N/A0.6 $1.08 2/28/2023266,100 shares $409,794.00 -20.6%N/A0.4 $1.54 2/15/2023335,200 shares $526,264.00 +74.6%N/A0.6 $1.57 1/31/2023192,000 shares $309,120.00 -11.0%N/A0.3 $1.61 1/15/2023215,800 shares $334,490.00 +572.3%N/A0.7 $1.55 12/30/202232,100 shares $56,977.50 -9.8%N/A0.2 $1.78 12/15/202235,600 shares $71,200.00 +16.0%N/A0.5 $2.00 11/30/202230,700 shares $66,926.00 -26.0%N/A0 $2.18 11/15/202241,500 shares $97,940.00 -39.4%N/A0.1 $2.36 10/31/202268,500 shares $178,100.00 -45.8%N/A0.1 $2.60 10/15/2022126,300 shares $368,796.00 -36.5%N/A0.2 $2.92 9/30/2022198,800 shares $522,844.00 +9.7%N/A0.3 $2.63 9/15/2022181,200 shares $373,272.00 -0.7%N/A0.2 $2.06 8/31/2022182,400 shares $428,640.00 -2.6%N/A5.2 $2.35 8/15/2022187,200 shares $548,496.00 -3.8%N/A4.6 $2.93The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. EVAX Short Interest - Frequently Asked Questions What is Evaxion Biotech A/S's current short interest? Short interest is the volume of Evaxion Biotech A/S shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 42,600 shares of EVAX short. Learn More on Evaxion Biotech A/S's current short interest. Which institutional investors are shorting Evaxion Biotech A/S? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evaxion Biotech A/S: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Evaxion Biotech A/S's short interest increasing or decreasing? Evaxion Biotech A/S saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 42,600 shares, a drop of 0.9% from the previous total of 43,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Evaxion Biotech A/S's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Evaxion Biotech A/S: Aptose Biosciences Inc. (0.92%), Surrozen, Inc. (0.56%), PharmaCyte Biotech, Inc. (0.60%), Senti Biosciences, Inc. (0.80%), Coeptis Therapeutics Holdings, Inc. (0.47%), Pluri Inc. (0.33%), Genetic Technologies Limited (0.30%), CASI Pharmaceuticals, Inc. (1.31%), Organovo Holdings, Inc. (1.61%), IN8bio, Inc. (0.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Evaxion Biotech A/S stock? Short selling EVAX is an investing strategy that aims to generate trading profit from Evaxion Biotech A/S as its price is falling. EVAX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evaxion Biotech A/S? A short squeeze for Evaxion Biotech A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVAX, which in turn drives the price of the stock up even further. How often is Evaxion Biotech A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVAX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Aptose Biosciences Short Interest Data Surrozen Short Interest Data PharmaCyte Biotech Short Interest Data Senti Biosciences Short Interest Data Coeptis Therapeutics Short Interest Data Pluri Short Interest Data Genetic Technologies Short Interest Data CASI Pharmaceuticals Short Interest Data Organovo Short Interest Data IN8bio Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVAX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm Press